UB Paderborn / Katalog / Suche / in CDI

Biopsy in hepatocellulary carcinoma - yes

Deutsche medizinische Wochenschrift (1946), 2014-09, Vol.139 (36), p.1776

Schuchmann, M

2014

Link zum Volltext

Verfügbarkeit prüfen

Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors

Cell death and differentiation, 2015-04, Vol.22 (5), p.826-837

2015

Link zum Volltext

Verfügbarkeit prüfen

Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells

Cell death & disease, 2013-07, Vol.4 (7), p.e712-e712

2013

Link zum Volltext

Verfügbarkeit prüfen

Loss of Cellular Flice-Inhibitory Protein Promotes Cholestasis-Induced Hepatocellular Injury and Inflammation in Bile Duct Ligated Mice

Journal of hepatology, 2016, Vol.64 (2), p.S637-S638

2016

Link zum Volltext

Verfügbarkeit prüfen

Voluntary Distance Running Prevents Inflammatory Liver Injury in Mice

Journal of hepatology, 2016, Vol.64 (2), p.S353-S353

2016

Link zum Volltext

Verfügbarkeit prüfen

Correlation of Multislice CT and Histomorphology in HCC Following TACE: Predictors of Outcome

Cardiovascular and interventional radiology, 2008-07, Vol.31 (4), p.768-777

2008

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment

Journal of viral hepatitis, 2014-09, Vol.21 (9), p.633-641

2014

Link zum Volltext

Verfügbarkeit prüfen

Tacrolimus Monotherapy Without Steroids After Liver Transplantation – A Prospective Randomized Double‐Blinded Placebo‐Controlled Trial

American journal of transplantation, 2007-06, Vol.7 (6), p.1616-1623

2007

Link zum Volltext

Verfügbarkeit prüfen

291 Bcl-3 MODULATES GalN AND LPS-INDUCED LIVER INJURY IN-VIVO

Journal of hepatology, 2013-04, Vol.58, p.S123-S123

2013

Link zum Volltext

Verfügbarkeit prüfen

Add on Interferon-Alpha-2a for the Treatment of HBeAg Negative Hepatitis B Patients Receiving Effective Nucleos(t)ide Therapy: Interim Results of the Prospective Multicentre PADD-On Trial

Journal of hepatology, 2016, Vol.64 (2), p.S221-S221

2016

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoids

Internal medicine journal, 2014-01, Vol.44 (1), p.90-92

2014

Link zum Volltext

Verfügbarkeit prüfen

387 A NOVEL ROLE OF IL-33 IN LIVER FIBROSIS

Journal of hepatology, 2012-04, Vol.56, p.S156-S156

2012

Link zum Volltext

Verfügbarkeit prüfen

Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort

Infection, 2015-06, Vol.43 (3), p.299-305

2015

Link zum Volltext

Verfügbarkeit prüfen

747 HEPATOCELLULAR CARCINOMA (HCC) IN NASH - CLINICAL CHARACTERISTICS DERIVED FROM A LARGE COHORT

Journal of hepatology, 2012-04, Vol.56, p.S294-S294

2012

Link zum Volltext

Verfügbarkeit prüfen

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN

Journal of hepatology, 2014-04, Vol.60 (1), p.S465-S465

2014

Link zum Volltext

Verfügbarkeit prüfen

P725 IMPACT OF THE rs8099917 SNP ON SVR12 IN PATIENTS WITH HCV GT-1 INFECTION TREATED WITH FALDAPREVIR, DELEOBUVIR AND RIBAVIRIN

Journal of hepatology, 2014-04, Vol.60 (1), p.S311-S312

2014

Link zum Volltext

Verfügbarkeit prüfen

P1125 PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: A POOLED ANALYSIS OF TWO PHASE III TRIALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S454-S455

2014

Link zum Volltext

Verfügbarkeit prüfen

P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2a AND RIBAVIRIN IN 253 HCV GENOTYPE 1 NONRESPONDER PATIENTS IN A REAL-WORLD SETTING

Journal of hepatology, 2014-04, Vol.60 (1), p.S466-S466

2014

Link zum Volltext

Verfügbarkeit prüfen

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS

Journal of hepatology, 2013-04, Vol.58, p.S329-S329

2013

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature

Zeitschrift fur Gastroenterologie, 2014-01, Vol.52 (1), p.58

2014

Link zum Volltext

Verfügbarkeit prüfen

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

Journal of hepatology, 2013-04, Vol.58, p.S357-S358

2013

Link zum Volltext

Verfügbarkeit prüfen

OP-11 Serum C-reactive protein (CRP) as biomarker for overall survival in patients with sorafenib therapy with hepatocellular carcinoma

Digestive and liver disease, 2013-04, Vol.45, p.S252-S252

2013

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy

Oncology reports, 2006, Vol.15 (1), p.227-230

2006

Link zum Volltext

Verfügbarkeit prüfen

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

Cardiovascular and interventional radiology, 2010-02, Vol.33 (1), p.41-52

2010

Link zum Volltext

Verfügbarkeit prüfen

331 ACUTE LIVER FAILURE IN MICE FOLLOWING DELETION OF CFLIP - A KEY ROLE OF APOPTOSIS SIGNALING PATHWAYS IN TISSUE HOMEOSTASIS

Journal of hepatology, 2012-04, Vol.56, p.S135-S135

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Biopsy in hepatocellulary carcinoma - yes

Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors

Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells

Loss of Cellular Flice-Inhibitory Protein Promotes Cholestasis-Induced Hepatocellular Injury and Inflammation in Bile Duct Ligated Mice

Voluntary Distance Running Prevents Inflammatory Liver Injury in Mice

Correlation of Multislice CT and Histomorphology in HCC Following TACE: Predictors of Outcome

Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment

Tacrolimus Monotherapy Without Steroids After Liver Transplantation – A Prospective Randomized Double‐Blinded Placebo‐Controlled Trial

291 Bcl-3 MODULATES GalN AND LPS-INDUCED LIVER INJURY IN-VIVO

Add on Interferon-Alpha-2a for the Treatment of HBeAg Negative Hepatitis B Patients Receiving Effective Nucleos(t)ide Therapy: Interim Results of the Prospective Multicentre PADD-On Trial

Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoids

387 A NOVEL ROLE OF IL-33 IN LIVER FIBROSIS

Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort

747 HEPATOCELLULAR CARCINOMA (HCC) IN NASH - CLINICAL CHARACTERISTICS DERIVED FROM A LARGE COHORT

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN

P725 IMPACT OF THE rs8099917 SNP ON SVR12 IN PATIENTS WITH HCV GT-1 INFECTION TREATED WITH FALDAPREVIR, DELEOBUVIR AND RIBAVIRIN

P1125 PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: A POOLED ANALYSIS OF TWO PHASE III TRIALS

P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2a AND RIBAVIRIN IN 253 HCV GENOTYPE 1 NONRESPONDER PATIENTS IN A REAL-WORLD SETTING

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS

Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

OP-11 Serum C-reactive protein (CRP) as biomarker for overall survival in patients with sorafenib therapy with hepatocellular carcinoma

Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

331 ACUTE LIVER FAILURE IN MICE FOLLOWING DELETION OF CFLIP - A KEY ROLE OF APOPTOSIS SIGNALING PATHWAYS IN TISSUE HOMEOSTASIS

Suchergebnisse filtern